RESQ PHARMA
ResQ Pharma is a research & development company. Its lead program, LipidRescue Therapy (LRT) is an already used off-label treatment for various non-opiate drug overdoses and poisonings including all local anesthetics (Lidocaine, Bupivacaine, etc...), benzodiazepines and psychotherapeutics (all antidepres). The Company was formed to commercialize LRT which is a repurposing of a lipid emulsion that is FDA and EMA approved as a nutritional supplement. ResQ Pharma plans to file applications for m... arket approval for both the EU and USA by the 1st quarter of 2017. Applications for Orphan Drug Designation are pending with both the FDA and EMA currently. This lipid emulsion has been used around the world since 2010 as Lipid Rescue Therapy (LRT). The problem is that it is not regulatorily approved as a treatment for overdoses and poisonings. Therefore it cannot be marketed and many in the healthcare community are not aware of product. Approximately 47,000 people died in 2015 from drug overdoses and poisonings, approximately 40% likely treatable with LRT.
RESQ PHARMA
Industry:
Biopharma Biotechnology Medical
Founded:
2010-01-01
Address:
Chicago, Illinois, United States
Country:
United States
Website Url:
http://www.resqpharma.com
Total Employee:
11+
Status:
Active
Contact:
224-880-6001
Email Addresses:
[email protected]
Total Funding:
2.28 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS AWS Global Accelerator
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.resqpharma.com
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 76.223.105.230
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "ResQ Pharma"
ResQ Pharma, Inc
LipidRescue® is the infusion of lipid emulsion to treat toxicity caused by lipid soluble drugs. NOTE: LipidRescue® is an investigational drug; its safety and efficacy have not been …See details»
About Us - ResQ Pharma, Inc
Dr. Mukesh Kumar is CEO and Founder of FDAMap, a Washington DC-based firm helping manufacturers and developers of FDA-regulated products in regulatory affairs, quality …See details»
ResQ Pharma - Crunchbase Company Profile & Funding
ResQ Pharma is a research & development company. Its lead program, LipidRescue Therapy (LRT) is an already used off-label treatment for various non-opiate drug overdoses and …See details»
ResQ Pharma Company Profile 2024: Valuation, Funding
Operator of a clinical-stage pharmaceutical platform intended to develop and commercialize lipid emulsion for the treatment of toxicity caused by lipid-soluble drugs.See details»
ResQ Pharma, Inc. | LinkedIn
ResQ Pharma is a research & development company. Its lead program, LipidRescue Therapy (LRT) is an antidote for various non-opiate drug overdoses and poisonings including all local...See details»
Resq Pharma, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Resq Pharma, Inc. of Chicago, IL. Get the latest business insights from Dun & Bradstreet.See details»
ResQ Pharma Inc - Company Profile and News - Bloomberg Markets
ResQ Pharma, Inc. operates as a biotechnology company. The Company develops medicines for the treatment of various lipophilic drug overdoses and poisonings. ResQ Pharma serves …See details»
Background - ResQ Pharma, Inc
ResQ Pharma held a preNDA meeting with FDA in December 2020 and filed an NDA for the LAST indication in December, 2022. Combining its use in LAST, non-opiate drug overdoses …See details»
ResQ Pharma - Products, Competitors, Financials, Employees ...
ResQ Pharma is a pharmaceutical company that focuses on developing treatments for drug toxicity. The company's main offering is LipidRescue, an investigational lipid emulsion therapy …See details»
ResQ Pharma - Craft
ResQ Pharma is a research and development company providing LipidRescue therapy (LRT). LRT is a lipid emulsion product that is used to treat various non-opioid drug overdoses …See details»
ResQ Pharma - Funding, Financials, Valuation & Investors
ResQ Pharma is a research & development company that develops drugs and therapies for treating lipophilic drug overdoses and poisonings.See details»
ResQ Pharma - Overview, News & Similar companies - ZoomInfo
ResQ Pharma contact info: Phone number: (847) 322-7971 Website: www.resqpharma.com What does ResQ Pharma do? ResQ Pharma, Inc., is a biopharmaceutical company created to …See details»
Working At ResQ Pharma: Company Overview and Culture - Zippia
Resqpharma.com. Organization Type. Private. Social Media. ResQ Pharma is a research & development company. Its lead program, LipidRescue Therapy (LRT) is an already used off …See details»
ResQ Pharma Receives FDA Orphan Drug Designation for …
Jun 15, 2017 · CHICAGO-- ( BUSINESS WIRE )--ResQ Pharma, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for …See details»
Contact Us - ResQ Pharma, Inc
If you have any questions or would like to learn more about ResQ Pharma, please get in touch with our team by sending us a message below. This site is protected by reCAPTCHA and the …See details»
LipidRescue Therapy(ResQPharma) - Drug Targets, Indications
LipidRescue Therapy (ResQPharma), Initially developed by ResQ Pharma, Inc., Now, its global highest R&D status is Phase 3, Therapeutic Areas: Cardiovascular Diseases,Other Diseases, …See details»
ResQ Pharma Receives PDUFA Date for LipidRescue™ as a …
CHICAGO, Nov. 11, 2024 /PRNewswire/ -- ResQ Pharma, Inc., a Chicago -based pharmaceutical company developing and commercializing innovative drug therapies, today announced that it …See details»
Advisors - ResQ Pharma, Inc
Dr. Suresh is the current Chair of the Department of Anesthesiology at Ann & Robert H. Lurie Children’s Hospital of Chicago. He holds an MBA from Kellogg School of Business and is …See details»
History - ResQ Pharma, Inc
ResQ Pharma received Orphan Drug designation from the FDA for use of LipidRescue® Therapy in the treatment of LAST. ResQ anticipates filing an NDA for a kit to treat LAST in 2024.See details»
LOCAL ANESTHETIC SYSTEMIC TOXICITY (LAST) - ResQ Pharma, Inc
LAST is a life-threatening medical complication that occurs when local anesthetics enter the circulation producing potentially severe cardiac and neurological toxicity.See details»